YCYiming Chao

Yiming Chao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yiming Chao has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Blood originates in hypoblasts during embryonic development

    by Yiming Chao, Hongji Li, Lu Liu, Zhengyi Tay, Shihui Zhang, Xiaolin Xu, Shao Xu, Yang Xiang, Degong Ruan, Yuanhua Huang, et al.

    Blood is essential for oxygen supply throughout life. The emergence of blood in the human embryo remains poorly understood. Our study leverages multiple stem cell embryo models and advanced lineage barcoding to unveil that hypoblast, originally regarded as forming the yolk sac wall, is heterogeneous and contributes to CDX2+ extraembryonic mesoderm, followed by hemoglobin+ cells as the first blood cells. CDX2 marks the hypoblast-to-hemoglobin+ cell trajectory that functionally sustains oxygen levels in embryo models. These hemoglobin+ cells molecularly and functionally resemble phagocytes. We show that the erythro-core regulatory network is poised in hypoblasts, and its boost endows erythropoiesis to both hypoblasts and phagocytes. Hypoblasts are the origin of the first blood in humans and non-human primates, providing a conceptual framework that earlier blood generation than expected fills the gap in the establishment of circulation. Further, the hypoblast is a place where primates may repurpose the phagocyte program to carry oxygen throughout embryos. Highlights: Barcode-traced hypoblast fate in human embryo models; The first blood comes from the hypoblast that contributes to hemoglobin+ phagocyte-like cells; CDX2 marks hypoblast blood that sustains oxygen supply in embryos before heart formation; Erythro-core regulatory network endows erythropoiesis to human hypoblasts and phagocytes.


  • Open Access

    Unveiling Clonal Cell Fate and Differentiation Dynamics: A Hybrid NeuralODE-Gillespie Approach

    by Mingze Gao, Melania Barile, Shirom Chabra, Myriam Haltalli, Emily F. Calderbank, Yiming Chao, Elisa Laurenti, Bertie Gottgens, Yuanhua Huang

    Recent lineage tracing single-cell techniques (LT-scSeq), e.g., the Lineage And RNA RecoverY (LARRY) barcoding system, have enabled clonally resolved interpretation of differentiation trajectories. However, the heterogeneity of clone-specific kinetics remains understudied, both quantitatively and in terms of interpretability, thus limiting the power of bar-coding systems to unravel how heterogeneous stem cell clones drive overall cell population dynamics. Here, we present CLADES, a NeuralODE-based framework to faithfully estimate clone-specific kinetics of cell states from newly generated and publicly available human cord blood LARRY LT-scSeq data. By incorporating a stochastic simulation algorithm (SSA) and differential expression gene (DEGs) analysis, CLADES yields cell division dynamics across differentiation timecourses and fate bias predictions for the early progenitor cells. Moreover, clone-level quantitative behaviours can be grouped into characteristic types by pooling individual clones into meta-clones. By benchmarking with CoSpar, we found that CLADES improves fate bias prediction accuracy at the meta-clone level. In conclusion, we report a broadly applicable approach to robustly quantify differentiation kinetics using meta-clones while providing valuable insights into the fate bias of cellular populations for any organ system maintained by a pool of heterogeneous stem and progenitor cells.


  • Open Access

    Lipidic and senescent macrophages predict progression and response to combinatorial immunotherapy in triple-negative breast cancer

    by Chun Lai Chan, Alex To, Shihui Zhang, Jason Wing Hon Wong, Yuanhua Huang, Yiming Chao, Ryohichi Sugimura

    Immune cell subsets in the tumor predict prognosis. Identifying reliable subsets consistently in multiple patients is clinically important. What’s more advantageous to the field is if such subsets can be a target of immunotherapy. Here we analyzed single-cell RNA-sequencing datasets of patients with triple-negative breast cancer and identified APOE or FABP5-expressing macrophages correlated with poor prognosis. Further validation with TCGA-BRCA cohort detailed molecular signatures of these macrophages as lipidic and senescent. Our receptor-ligand mapping identified lipidic and senescent macrophages both suppress T-lymphoid and myeloid immunogenicity. Finally, we discovered that immune checkpoint therapy combined with chemotherapy reprogrammed anti-tumor microenvironment enriched with FOLR2 + macrophages facilitated T-cell activations. This suggests that lipidic and senescent macrophages could be a therapeutic target of immune checkpoint therapy.

  • Open Access

    PD-L1 regulates inflammatory programs of macrophages from human pluripotent stem cells

    by Handi Cao, Yang Xiang, Shihui Zhang, Yiming Chao, Jilong Guo, Theo Aurich, Joshua Wk Ho, Yuanhua Huang, Pentao Liu, Ryohichi Sugimura

    Programmed death ligand 1 (PD-L1) serves as a pivotal immune checkpoint in both the innate and adaptive immune systems. PD-L1 is expressed in macrophages in response to IFNγ. We examined whether PD-L1 might regulate macrophage development. We established PD-L1 KO (CD274-/-) human pluripotent stem cells and differentiated them into macrophages and observed a 60% reduction in CD11B+CD45+macrophages inCD274-/-; this was orthogonally verified, with the PD-L1 inhibitor BMS-1166 reducing macrophages to the same fold. Single-cell RNA sequencing further confirmed the down-regulation of the macrophage-defining transcription factorsSPI1andMAFB. Furthermore,CD274-/-macrophages reduced the level of inflammatory signals such as NF-κB and TNF, and chemokine secretion of the CXCL and CCL families. Anti-inflammatory TGF-β was up-regulated. Finally, we identified thatCD274-/-macrophages significantly down-regulated interferon-stimulated genes despite the presence of IFNγ in the differentiation media. These data suggest that PD-L1 regulates inflammatory programs of macrophages from human pluripotent stem cells.


  • Open Access

    Organoid-based single-cell spatiotemporal gene expression landscape of human embryonic development and hematopoiesis

    by Yiming Chao, Yang Xiang, Jiashun Xiao, Weizhong Zheng, Mo R. Ebrahimkhani, Can Yang, Angela Ruohao Wu, Pentao Liu, Yuanhua Huang, Ryohichi Sugimura


  • Open Access

    PD-L1 regulates inflammatory macrophage development from human pluripotent stem cells by maintaining interferon-gamma signal

    by Handi Cao, Yang Xiang, Shihui Zhang, Yiming Chao, Jilong Guo, Joshua W. K. Ho, Yuanhua Huang, Pentao Liu, Ryohichi Sugimura

    PD-L1 (programmed death-ligand 1) serves as a pivotal immune checkpoint in both the innate and adaptive immune systems. PD-L1 is expressed in macrophages in response to interferon-gamma (IFNγ). We examined whether PD-L1 might regulate macrophage development. We established PD-L1 -/- human pluripotent stem cells, differentiated them into macrophages, and observed a 60% reduction of CD11B + CD45 + macrophages in PD-L1 -/- , orthogonally verified with PD-L1 inhibitor BMS-1166 reduced macrophages to the same fold. Single-cell RNA sequencing further confirmed the 60% reduction of macrophages as well as the down-regulation of macrophage-defining transcription factors SPI1, KLF6 , and MAFB . Further, PD-L1 -/- macrophages reduced the level of inflammatory signals such as NFκB, TNF, and chemokines CXCL and CCL families. Whilst anti-inflammatory TGF-β was upregulated. Finally, we identified that PD-L1 -/- macrophages significantly down-regulated interferon-stimulated genes (ISGs) despite IFNγ in differentiation media. Mechanistically, PD-L1 -/- macrophages reduced IFNGR1 expression explaining that cells could not respond to IFNγ. These data suggest that PD-L1 regulates inflammatory macrophage development by maintaining the IFNγ signal.


  • Open Access

    Organoid-based single-cell spatiotemporal gene expression landscape of human embryonic development and hematopoiesis

    by Yiming Chao, Yang Xiang, Jiashun Xiao, Shihui Zhang, Weizhong Zheng, Xiaomeng Wan, Zhuoxuan Li, Mingze Gao, Gefei Wang, Zhilin Chen, et al.

    Single-cell level characterization of embryonic development is a major benchmark of human developmental biology. Spatiotemporal analysis of stem-cell-derived embryos offers conceptual and technical advances in the field. Here, we defined the single-cell spatiotemporal gene expression landscape of human embryonic development with stem-cell-derived organoids. We established the human embryonic organoid (HEMO) from expanded potential stem cells and achieved both embryonic and extraembryonic tissues in the same organoid. Time-series single-cell RNA sequencing paired with single-cell resolution spatial revealed human embryonic development signatures such as extraembryonic placenta, yolk sac hematopoiesis neural crest, blood vessels, and cardiac mesoderm. Hematopoietic tissues eventually predominated HEMO with erythropoiesis, mekagaryopiesis, and myelopoiesis. Cell-cell communication network analysis demonstrated that trophoblast-like tissues supplied WNT signaling in neural crest cells to facilitate maturation and migration. Single-cell resolution spatial transcriptomics defined the yolk sac erythro-megakaryopoietic niche. Vitronectin-integrin signaling, a major contributor to megakaryocyte maturation, was predominant in the yolk sac niche in HEMO and to human fetal samples. Overall, our study advances the spatiotemporal analysis of human embryonic development in stem-cell-derived organoids. Highlights: Modeling human embryonic development from stem cells Used of both 10X Chromium and 10X Visium to define the gene expression landscape of embryonic development and hematopoiesis WNT signaling as a regulator of neural crest maturation and EMT VTN-ITGA2B as the main contributor to Mk maturation within the yolk sac erythro-megakaryopoietic niche Graphical


  • RGCC balances self-renewal and neuronal differentiation of neural stem cells in the developing mammalian neocortex

    by Zhenming Guo, Mengxia Chen, Yiming Chao, Chunhai Cai, Liangjie Liu, Li Zhao, Linbo Li, Qing-Ran Bai, Yanxin Xu, Weibo Niu, et al.

    During neocortical development, neural stem cells (NSCs) divide symmetrically to self-renew at the early stage and then divide asymmetrically to generate post-mitotic neurons. The molecular mechanisms regulating the balance between NSC self-renewal and neurogenesis are not fully understood. Using mouse in utero electroporation (IUE) technique and in vitro human NSC differentiation models including cerebral organoids (hCOs), we show here that regulator of cell cycle (RGCC) modulates NSC self-renewal and neuronal differentiation by affecting cell cycle regulation and spindle orientation. RGCC deficiency hampers normal cell cycle process and dysregulates the mitotic spindle, thus driving more cells to divide asymmetrically. These modulations diminish the NSC population and cause NSC pre-differentiation that eventually leads to brain developmental malformation in hCOs. We further show that RGCC might regulate NSC spindle orientation by affecting the organization of centrosome and microtubules. Our results demonstrate that RGCC is essential to maintain the NSC pool during cortical development and suggest that RGCC defects could have etiological roles in human brain malformations.